Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers

We began analyzing https://www.nature.com/articles/onc201223, but it redirected us to https://www.nature.com/articles/onc201223. The analysis below is for the second page.

Title[redir]:
Critical role of the death receptor pathway in the antitumoral effects induced by hispanolone derivatives | Oncogene
Description:
Labdane diterpenoids have a broad spectrum of biological activities including antibacterial, antiviral and anti-inflammatory properties. However, little is known about their possible role in the apoptotic cell death machinery. Here, we report that hispanolone derivatives, a group of labdane diterpenoids, induce apoptosis in different tumor cell lines by activating caspase-8 with subsequent participation of mitochondrial signaling. Activation of caspase-8 by hispanolone derivatives was followed by a decrease in mitochondrial membrane potential, the release of apoptotic factors from mitochondria to the cytosol, and activation of caspases-9 and 3. Hispanolone derivatives also led to a time-dependent cleavage of Bid. Inhibition of caspase-8 abrogated these processes, suggesting that the death receptor pathway has a critical role in the apoptotic events induced by hispanolone derivatives. In addition, silencing death receptors with small interfering RNA s or pretreating cells with neutralizing antibodies to Fas ligand, tumor necrosis factor receptor 1 (TNF-R1), and TNF-α receptor 2 (TRAIL) inhibited diterpenoid-induced apoptosis, revealing it to be dependent on these death receptors. Interestingly, hispanolone derivatives had no effect on non-tumor cells. Consistently, in vivo bioluminescence imaging corroborates this antineoplasic effect, as hispanolone derivatives significantly decrease cancer growth in tumor xenograft assays. These data demostrate the antitumoral effects of hispanolone derivatives and provide relevant preclinical validation for the use of these compounds as potent therapeutic agents in cancer treatment.

Matching Content Categories {📚}

  • Education
  • Social Networks
  • Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We don't see any clear sign of profit-making.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Doi.org could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

article, google, scholar, cas, nature, apoptosis, death, cancer, derivatives, hispanolone, access, cell, activation, cells, content, information, las, caspase, cookies, oncogene, receptor, pathway, effects, diterpenoids, inhibition, chem, madrid, privacy, data, critical, role, heras, hortelano, open, rodriguez, pharmacol, lee, nfkappa, spain, antitumoral, través, lópezfontal, cuadrado, apoptotic, receptors, agents, activity, med, biol, lin,

Topics {✒️}

nature portfolio permissions reprints privacy policy author information authors nature 1996 nature advertising social media enhanced anti-tumor therapy cancer therapy-induced apoptosis experimental anti-leukemic drug kindly provide luc-b16f10 cold-water soluble polysaccharide lps-stimulated macrophage raw264 nitric oxide-dependent apoptosis inhibited diterpenoid-induced apoptosis natural origin-biological activities transcription factor nf-kappab springerlink instant access dna-binding activity permissions labdane-type diterpenoids ent-kaurene derivatives personal data silencing death receptors de las heras anti-inflammatory activity human cancer cells trail-induced apoptosis targeting death receptors data protection data demostrate anti-inflammatory properties andrographolide-induced apoptosis privacy inhibits nf-kappa apoptotic events induced facultad de farmacia small interfering rna issue learn apoptotic cell death exhibits antitumor activity 1h-indole derivatives nuclear factor kappa macrophage eicosanoid biosynthesis explore content subscription content death receptor pathway andrographolide attenuates inflammation cancer therapy

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Critical role of the death receptor pathway in the antitumoral effects induced by hispanolone derivatives
         description:Labdane diterpenoids have a broad spectrum of biological activities including antibacterial, antiviral and anti-inflammatory properties. However, little is known about their possible role in the apoptotic cell death machinery. Here, we report that hispanolone derivatives, a group of labdane diterpenoids, induce apoptosis in different tumor cell lines by activating caspase-8 with subsequent participation of mitochondrial signaling. Activation of caspase-8 by hispanolone derivatives was followed by a decrease in mitochondrial membrane potential, the release of apoptotic factors from mitochondria to the cytosol, and activation of caspases-9 and 3. Hispanolone derivatives also led to a time-dependent cleavage of Bid. Inhibition of caspase-8 abrogated these processes, suggesting that the death receptor pathway has a critical role in the apoptotic events induced by hispanolone derivatives. In addition, silencing death receptors with small interfering RNA s or pretreating cells with neutralizing antibodies to Fas ligand, tumor necrosis factor receptor 1 (TNF-R1), and TNF-α receptor 2 (TRAIL) inhibited diterpenoid-induced apoptosis, revealing it to be dependent on these death receptors. Interestingly, hispanolone derivatives had no effect on non-tumor cells. Consistently, in vivo bioluminescence imaging corroborates this antineoplasic effect, as hispanolone derivatives significantly decrease cancer growth in tumor xenograft assays. These data demostrate the antitumoral effects of hispanolone derivatives and provide relevant preclinical validation for the use of these compounds as potent therapeutic agents in cancer treatment.
         datePublished:2012-02-06T00:00:00Z
         dateModified:2012-02-06T00:00:00Z
         pageStart:259
         pageEnd:268
         sameAs:https://doi.org/10.1038/onc.2012.23
         keywords:
            Apoptosis
            Cancer therapy
            Mechanism of action
            hispanolone derivatives
            apoptosis
            death receptors
            TRAIL
            caspase-8
            Medicine/Public Health
            general
            Internal Medicine
            Cell Biology
            Human Genetics
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2012.23/MediaObjects/41388_2013_Article_BFonc201223_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2012.23/MediaObjects/41388_2013_Article_BFonc201223_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2012.23/MediaObjects/41388_2013_Article_BFonc201223_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2012.23/MediaObjects/41388_2013_Article_BFonc201223_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2012.23/MediaObjects/41388_2013_Article_BFonc201223_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2012.23/MediaObjects/41388_2013_Article_BFonc201223_Fig6_HTML.jpg
         isPartOf:
            name:Oncogene
            issn:
               1476-5594
               0950-9232
            volumeNumber:32
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:P G Través
               affiliation:
                     name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM)
                     address:
                        name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain
                        type:PostalAddress
                     type:Organization
                     name:These authors contributed equally to this work
                     address:
                        name:These authors contributed equally to this work,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:R López-Fontal
               affiliation:
                     name:Centro Nacional de Investigaciones Cardiovasculares (CNIC)
                     address:
                        name:Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
                        type:PostalAddress
                     type:Organization
                     name:These authors contributed equally to this work
                     address:
                        name:These authors contributed equally to this work,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:I Cuadrado
               affiliation:
                     name:Universidad Complutense de Madrid (UCM)
                     address:
                        name:Departamento de Farmacología. Facultad de Farmacia, Universidad Complutense de Madrid (UCM), Madrid, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A Luque
               affiliation:
                     name:Oncohematología y Trasplante. FIB Hospital Universitario Niño Jesús and IIS Hospital La Princesa
                     address:
                        name:Oncohematología y Trasplante. FIB Hospital Universitario Niño Jesús and IIS Hospital La Princesa, Madrid, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:L Boscá
               affiliation:
                     name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM)
                     address:
                        name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:B de las Heras
               affiliation:
                     name:Universidad Complutense de Madrid (UCM)
                     address:
                        name:Departamento de Farmacología. Facultad de Farmacia, Universidad Complutense de Madrid (UCM), Madrid, Spain
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:S Hortelano
               affiliation:
                     name:Unidad de Inflamación y Cáncer, Área de Biología Celular y Desarrollo, Centro Nacional de Microbiología, Instituto de Salud Carlos III
                     address:
                        name:Unidad de Inflamación y Cáncer, Área de Biología Celular y Desarrollo, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Critical role of the death receptor pathway in the antitumoral effects induced by hispanolone derivatives
      description:Labdane diterpenoids have a broad spectrum of biological activities including antibacterial, antiviral and anti-inflammatory properties. However, little is known about their possible role in the apoptotic cell death machinery. Here, we report that hispanolone derivatives, a group of labdane diterpenoids, induce apoptosis in different tumor cell lines by activating caspase-8 with subsequent participation of mitochondrial signaling. Activation of caspase-8 by hispanolone derivatives was followed by a decrease in mitochondrial membrane potential, the release of apoptotic factors from mitochondria to the cytosol, and activation of caspases-9 and 3. Hispanolone derivatives also led to a time-dependent cleavage of Bid. Inhibition of caspase-8 abrogated these processes, suggesting that the death receptor pathway has a critical role in the apoptotic events induced by hispanolone derivatives. In addition, silencing death receptors with small interfering RNA s or pretreating cells with neutralizing antibodies to Fas ligand, tumor necrosis factor receptor 1 (TNF-R1), and TNF-α receptor 2 (TRAIL) inhibited diterpenoid-induced apoptosis, revealing it to be dependent on these death receptors. Interestingly, hispanolone derivatives had no effect on non-tumor cells. Consistently, in vivo bioluminescence imaging corroborates this antineoplasic effect, as hispanolone derivatives significantly decrease cancer growth in tumor xenograft assays. These data demostrate the antitumoral effects of hispanolone derivatives and provide relevant preclinical validation for the use of these compounds as potent therapeutic agents in cancer treatment.
      datePublished:2012-02-06T00:00:00Z
      dateModified:2012-02-06T00:00:00Z
      pageStart:259
      pageEnd:268
      sameAs:https://doi.org/10.1038/onc.2012.23
      keywords:
         Apoptosis
         Cancer therapy
         Mechanism of action
         hispanolone derivatives
         apoptosis
         death receptors
         TRAIL
         caspase-8
         Medicine/Public Health
         general
         Internal Medicine
         Cell Biology
         Human Genetics
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2012.23/MediaObjects/41388_2013_Article_BFonc201223_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2012.23/MediaObjects/41388_2013_Article_BFonc201223_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2012.23/MediaObjects/41388_2013_Article_BFonc201223_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2012.23/MediaObjects/41388_2013_Article_BFonc201223_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2012.23/MediaObjects/41388_2013_Article_BFonc201223_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2012.23/MediaObjects/41388_2013_Article_BFonc201223_Fig6_HTML.jpg
      isPartOf:
         name:Oncogene
         issn:
            1476-5594
            0950-9232
         volumeNumber:32
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:P G Través
            affiliation:
                  name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM)
                  address:
                     name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain
                     type:PostalAddress
                  type:Organization
                  name:These authors contributed equally to this work
                  address:
                     name:These authors contributed equally to this work,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R López-Fontal
            affiliation:
                  name:Centro Nacional de Investigaciones Cardiovasculares (CNIC)
                  address:
                     name:Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
                     type:PostalAddress
                  type:Organization
                  name:These authors contributed equally to this work
                  address:
                     name:These authors contributed equally to this work,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:I Cuadrado
            affiliation:
                  name:Universidad Complutense de Madrid (UCM)
                  address:
                     name:Departamento de Farmacología. Facultad de Farmacia, Universidad Complutense de Madrid (UCM), Madrid, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A Luque
            affiliation:
                  name:Oncohematología y Trasplante. FIB Hospital Universitario Niño Jesús and IIS Hospital La Princesa
                  address:
                     name:Oncohematología y Trasplante. FIB Hospital Universitario Niño Jesús and IIS Hospital La Princesa, Madrid, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:L Boscá
            affiliation:
                  name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM)
                  address:
                     name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:B de las Heras
            affiliation:
                  name:Universidad Complutense de Madrid (UCM)
                  address:
                     name:Departamento de Farmacología. Facultad de Farmacia, Universidad Complutense de Madrid (UCM), Madrid, Spain
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:S Hortelano
            affiliation:
                  name:Unidad de Inflamación y Cáncer, Área de Biología Celular y Desarrollo, Centro Nacional de Microbiología, Instituto de Salud Carlos III
                  address:
                     name:Unidad de Inflamación y Cáncer, Área de Biología Celular y Desarrollo, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Oncogene
      issn:
         1476-5594
         0950-9232
      volumeNumber:32
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM)
      address:
         name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain
         type:PostalAddress
      name:These authors contributed equally to this work
      address:
         name:These authors contributed equally to this work,
         type:PostalAddress
      name:Centro Nacional de Investigaciones Cardiovasculares (CNIC)
      address:
         name:Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
         type:PostalAddress
      name:These authors contributed equally to this work
      address:
         name:These authors contributed equally to this work,
         type:PostalAddress
      name:Universidad Complutense de Madrid (UCM)
      address:
         name:Departamento de Farmacología. Facultad de Farmacia, Universidad Complutense de Madrid (UCM), Madrid, Spain
         type:PostalAddress
      name:Oncohematología y Trasplante. FIB Hospital Universitario Niño Jesús and IIS Hospital La Princesa
      address:
         name:Oncohematología y Trasplante. FIB Hospital Universitario Niño Jesús and IIS Hospital La Princesa, Madrid, Spain
         type:PostalAddress
      name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM)
      address:
         name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain
         type:PostalAddress
      name:Universidad Complutense de Madrid (UCM)
      address:
         name:Departamento de Farmacología. Facultad de Farmacia, Universidad Complutense de Madrid (UCM), Madrid, Spain
         type:PostalAddress
      name:Unidad de Inflamación y Cáncer, Área de Biología Celular y Desarrollo, Centro Nacional de Microbiología, Instituto de Salud Carlos III
      address:
         name:Unidad de Inflamación y Cáncer, Área de Biología Celular y Desarrollo, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:P G Través
      affiliation:
            name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM)
            address:
               name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain
               type:PostalAddress
            type:Organization
            name:These authors contributed equally to this work
            address:
               name:These authors contributed equally to this work,
               type:PostalAddress
            type:Organization
      name:R López-Fontal
      affiliation:
            name:Centro Nacional de Investigaciones Cardiovasculares (CNIC)
            address:
               name:Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
               type:PostalAddress
            type:Organization
            name:These authors contributed equally to this work
            address:
               name:These authors contributed equally to this work,
               type:PostalAddress
            type:Organization
      name:I Cuadrado
      affiliation:
            name:Universidad Complutense de Madrid (UCM)
            address:
               name:Departamento de Farmacología. Facultad de Farmacia, Universidad Complutense de Madrid (UCM), Madrid, Spain
               type:PostalAddress
            type:Organization
      name:A Luque
      affiliation:
            name:Oncohematología y Trasplante. FIB Hospital Universitario Niño Jesús and IIS Hospital La Princesa
            address:
               name:Oncohematología y Trasplante. FIB Hospital Universitario Niño Jesús and IIS Hospital La Princesa, Madrid, Spain
               type:PostalAddress
            type:Organization
      name:L Boscá
      affiliation:
            name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM)
            address:
               name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain
               type:PostalAddress
            type:Organization
      name:B de las Heras
      affiliation:
            name:Universidad Complutense de Madrid (UCM)
            address:
               name:Departamento de Farmacología. Facultad de Farmacia, Universidad Complutense de Madrid (UCM), Madrid, Spain
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:S Hortelano
      affiliation:
            name:Unidad de Inflamación y Cáncer, Área de Biología Celular y Desarrollo, Centro Nacional de Microbiología, Instituto de Salud Carlos III
            address:
               name:Unidad de Inflamación y Cáncer, Área de Biología Celular y Desarrollo, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain
      name:These authors contributed equally to this work,
      name:Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
      name:These authors contributed equally to this work,
      name:Departamento de Farmacología. Facultad de Farmacia, Universidad Complutense de Madrid (UCM), Madrid, Spain
      name:Oncohematología y Trasplante. FIB Hospital Universitario Niño Jesús and IIS Hospital La Princesa, Madrid, Spain
      name:Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain
      name:Departamento de Farmacología. Facultad de Farmacia, Universidad Complutense de Madrid (UCM), Madrid, Spain
      name:Unidad de Inflamación y Cáncer, Área de Biología Celular y Desarrollo, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

Social Networks {👍}(1)

External Links {🔗}(189)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com
5.8s.